Previously treated cases tested for RR-/MDR-TB (%) in Guyana
Guyana: Previously treated cases tested for RR-/MDR-TB was 57.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Guyana, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Guyana is 57.0%, measured in 2024.
The figure is down 26.9% on the previous year and up 111.1% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Guyana peaked at 93.0% in 2019 and was at its lowest, 0.0%, in 2010.
That places Guyana 144th out of 180 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Guyana, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 10.0% | — |
| 2008 | 9.4% | -6.0% |
| 2010 | 0.0% | -100.0% |
| 2011 | 24.0% | — |
| 2012 | 0.4% | -98.3% |
| 2013 | 3.0% | +631.7% |
| 2014 | 27.0% | +800.0% |
| 2015 | 27.0% | +0.0% |
| 2016 | 37.0% | +37.0% |
| 2017 | 59.0% | +59.5% |
| 2019 | 93.0% | +57.6% |
| 2020 | 69.0% | -25.8% |
| 2021 | 92.0% | +33.3% |
| 2023 | 78.0% | -15.2% |
| 2024 | 57.0% | -26.9% |
Guyana compared with similar countries
- Guyana's 57.0% is below the median for high income countries, which is 83.0%, 69% of the median. (57 countries reporting)
- Guyana's 57.0% is below the median for Latin America & Caribbean, which is 85.0%, 67% of the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Guyana changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2014 | +800.0% | 3.0% | 27.0% |
| 2013 | +631.7% | 0.4% | 3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.7% | 9.4% | 10.0% | 2 |
| 2010s | 30.0% | 0.0% | 93.0% | 9 |
| 2020s | 74.0% | 57.0% | 92.0% | 4 |
Countries ranked near Guyana
More health data for Guyana
- Un projection of annual infant deaths, annual growth rate -1.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4509 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 62 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.39 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0477 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Guyana?
- Previously treated cases tested for rr-/mdr-tb in Guyana was 57.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Guyana?
- The highest recorded value was 93.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Guyana?
- The lowest recorded value was 0.0% in 2010.
- How does Guyana rank for previously treated cases tested for rr-/mdr-tb?
- Guyana ranks 144th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Guyana?
- Over the last ten years it is up 111.1%. The long-run trend across the full record is volatile.
- Where does this Guyana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).